Keywords: South Korea, Market, Biosimilars, R&D

Aging population will drive growth of South Korea’s health care industry, which will reach over $130 billion in 2014

Article | 18 March 2010

Combined sales of prescription and over-the-counter (OTC) medicines in South Korea reached 13,330 billion won ($10.45 billion) in 2009, according to Business Monitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in